NexGen Energy (NXE) — Stock Analysis 2026 [4.0]
Analysis as of 20 August 2026. NexGen Energy stock analysis. Price deck: base uranium US$90/lb U₃O₈ — the representative trailing average on the fixed US$60–120/lb grid — with every grid price run as a scenario (deep bear US$60, bear US$75, base US$90, bull US$105, deep bull US$120) and the analyst consensus as a 0% cross-check — no spot price. At C$14.55 the shares price in a market-implied uranium deck of ~US$87/lb. Market data is the 19 August 2026 TSX close; figures are Canadian dollars unless marked US$. Refreshed on each permitting, financing or construction milestone. Rating: ★★★★ Solid / Fairly valued (wide band).
This NexGen Energy (NXE) stock analysis covers a company building one mine: Rook I, home of the Arrow deposit in Saskatchewan’s Athabasca Basin, with 239.6 mlb of probable reserves at 2.37% U₃O₈ designed to produce 30 mlb a year. The thesis in one line: the asset is first-rate and now licensed and under construction, and at C$14.55 the shares sit close to a blended fair value of C$15.12 — the market already prices a large part of the build. Why now: licensed construction began on 8 June 2026 with C$1.17 billion of the remaining capital still unfunded, so the financing package decides how much of Arrow reaches today’s shareholder. To screen NexGen against every listed uranium name on reserves, grade and stage, use Metal Pilot’s uranium mining stock screener.
1. Snapshot & thesis
NexGen Energy Ltd. (TSX: NXE; NYSE: NXE) is a pre-production uranium company. By archetype it is a developer in the energy-metals sector (uranium): one project, licensed and under construction since June 2026, with no production yet. Its one project, Rook I, covers 32 contiguous mineral claims and 35,065 hectares in the southwestern Athabasca Basin; NexGen owns and operates it outright and also holds about 27.8% of the explorer IsoEnergy. The portfolio is one licensed project, one exploration corridor and one listed stake, with no revenue.
Figure 1. NexGen Energy in numbers
valued
Figure data: Table 1, the valuation in Section 7 and the scorecard in Section 9.
Table 1. NexGen Energy in numbers
| Metric | Value | As of |
|---|---|---|
| Share price / market capitalisation | C$14.55 (US$10.49) / C$9,756 m on 670.5 m basic shares | 19 Aug 2026 |
| Shares, basic / diluted | 670.5 m / 706.7 m | 4 Aug 2026 |
| Revenue | nil (pre-production) | FY2025 |
| Arrow probable reserve (100%) | 239.6 mlb at 2.37% U₃O₈ | eff. 21 Jan 2021 |
| Design output / cash operating cost | 30 mlb/yr / C$13.86/lb (US$9.98/lb), ITU study | 1 Aug 2024 |
| Cash margin at the ITU cash cost, US$90/lb | 88.9% | 20 Aug 2026 |
| Remaining pre-production capital | C$2,133.5 m of the ~C$2.2 bn estimate | 30 Jun 2026 |
| Net cash / convertibles at face | C$969.6 m / US$360 m | 30 Jun 2026 |
| Funding gap | C$1,173.6 m, 12.0% of market capitalisation | 30 Jun 2026 |
| NAV per share / P/NAV | C$6.64 / 2.19× | 20 Aug 2026 |
| Fair value (range) | C$15.12 (C$7.54–21.19) | 20 Aug 2026 |
| Market-implied uranium deck | ~US$87/lb | 20 Aug 2026 |
| Quality rating / valuation read | 4.0/5 Solid / Fairly valued (wide band), implied +3.9% | 20 Aug 2026 |
Source: NexGen’s Q2 2026 condensed interim financial statements and MD&A and the 2025 Annual Information Form (reserve, design, study costs); share price per stockanalysis.com at the 19 August 2026 close. Margin = (US$90 − US$9.98) ÷ US$90. NAV, fair value, funding gap and the market-implied deck per Section 7.
Thesis in brief. Bull: no listed developer holds a deposit of Arrow’s grade and size, and it now has every approval it needs; at US$90/lb the 2024 Interim Trend Update (ITU) puts after-tax free cash flow at C$1.82 billion a year over the first five years. Bear: it is one asset, its capital estimate has already risen from C$1.3 billion to about C$2.2 billion, no project debt is signed, and neither the first-production date nor the mine life is in the filings. What tips it: the terms of the project financing, and whether uranium holds near the ~US$87/lb the share price assumes.
How to read this analysis: the statcards and Section 9 give the verdict; Sections 2–6 give the evidence and Section 7 the valuation.
2. Assets & operations
For how uranium is priced and why term contracts matter to a developer, see the Uranium — A Complete Market Guide. This section covers the asset.
2.1 Portfolio overview
Table 2. NexGen asset portfolio
| Asset | Country | Stage | Interest | Output | Reserves | Life | Unit cost | Listing / operator |
|---|---|---|---|---|---|---|---|---|
| Rook I Project (Arrow) | Canada (Saskatchewan) | Licensed construction since 8 Jun 2026 | 100% | 30 mlb/yr design | 239.6 mlb Probable (NI 43-101, eff. 21 Jan 2021) | n/d | C$13.86/lb cash operating (ITU) | Private (wholly owned) / NexGen |
| Patterson Corridor East | Canada (Saskatchewan) | Exploration drilling | 100% | — | none declared | — | — | Private (wholly owned) / NexGen |
| IsoEnergy Ltd. | Canada | Uranium explorer (associate) | ~27.8% | — | — | — | — | Public (TSX: ISO) / IsoEnergy |
Source: NexGen’s Q2 2026 MD&A (interest, stage, IsoEnergy stake, ITU cost) and 2025 Annual Information Form (claims, design production); reserve per the 2024 Annual Information Form. Mine life is not in the filings on hand; 239.6 mlb at the 30 mlb/yr design rate is about eight years.
Concentration is total. At the base deck Rook I carries C$3,797.9 million of the C$3,888.3 million enterprise NAV (97.7%); the measured and indicated pounds outside the mine plan carry the other 2.3%. Patterson Corridor East has no declared resource and is not valued, and the IsoEnergy stake sits in the bridge with its market value not on record.
2.2 Value split
NexGen has no revenue, so both figures substitute the pre-revenue view: the enterprise NAV by component, and contained uranium by category.
Figure 2. Enterprise NAV by component, base case (C$ m)
Figure data: Section 7, Tables 9 and 10.
Figure 3. Contained U₃O₈ by category, Arrow (mlb, 100%)
Figure data: NexGen 2025 Annual Information Form resource table and the 2024 Annual Information Form reserve table, effective 21 January 2021.
2.3 Rook I Project and the Arrow deposit
Ownership and encumbrances. NexGen Energy Ltd. holds Rook I directly at 100% and operates it. In July 2025 it bought out Rio Tinto’s 10% production carried interest; a 2% net smelter return royalty in favour of Advance Royalty Corporation remains on certain claims, with buy-down terms in the Annual Information Form.
Approvals in hand. Saskatchewan’s environmental assessment approval came in November 2023. The Canadian Nuclear Safety Commission granted the federal approval and a Licence to Prepare Site and Construct on 5 March 2026, its conditions were resolved on 22 May 2026, and licensed construction began on 8 June 2026. Benefit Agreements are signed with all four primary Indigenous Nations. No approval for construction is outstanding.
Reserves and resources. The probable reserve is 4,575 kt at 2.37% U₃O₈ for 239.6 mlb (NI 43-101, effective 21 January 2021; no proven category). Measured and indicated resources, inclusive of the reserve, total 256.7 mlb at 3.10% — measured 2.18 Mt at 4.35% and indicated 1.57 Mt at 1.36% — with a further 4.40 Mt inferred at 0.83% (80.7 mlb).
Plan, capital and cost. The feasibility study (FS) designs a 1,300 t/d plant producing 30 mlb a year, with tailings returned underground. The ITU (costs as of 1 August 2024) raised pre-production capital from C$1.3 billion to about C$2.2 billion — C$310 million of inflation and C$590 million of added scope — lifted sustaining capital from C$362.4 million to about C$785 million including closure, and lifted the cash operating cost from US$5.69 to C$13.86/lb (US$9.98). After H1 2026 spending of C$54.5 million plus C$12.0 million of advances, C$2,133.5 million remains. The first-production date and the ramp by year are not filed.
Economics. On the ITU, the after-tax NPV at 8% is C$5.84 billion at US$90/lb (IRR 43.4%, payback 1.1 years) and C$2.10 billion at the FS’s US$50/lb base case; at US$100/lb it is C$6.79 billion (IRR 46.9%). The FS had put the US$90/lb NPV at C$7.20 billion — the ITU’s higher capital and operating costs take C$1.36 billion off it.
The asset risk is execution: engineering, procurement and front-end design are still being refined while construction proceeds.
2.4 Exploration and the IsoEnergy stake
Patterson Corridor East, on the Rook I claims, was drilled again in 2026 and has no declared resource. After C$721.6 million moved to mine property on licensing, exploration and evaluation assets stand at C$148.8 million. The ~27.8% IsoEnergy stake (30.0% at end-2025) is equity-accounted (fair value C$256.6 million at 30 June 2026, carried in Section 7); three NexGen directors — Curyer, McFadden and Patricio — also sit on its board.
2.5 Reserves, resources and costs
The group profile is Arrow’s: no production, 239.6 mlb in reserve, and a study cost base. Figure 4 shows how the ITU’s value moves with the uranium price — each US$10/lb adds about C$0.92–0.95 billion of NPV. On the FS’s own life-of-mine forecast at US$50/lb, gross revenue of C$15,573.2 million leaves C$7,012.4 million of post-tax cash flow after C$1,769.8 million of operating costs, C$1,573.9 million of capital, C$2,812.6 million of royalties and C$2,404.5 million of tax: royalties and tax, not mining costs, are the largest deductions.
Figure 4. Rook I after-tax NPV at 8% by uranium price, ITU (C$ bn, 100%)
Figure data: NexGen Q2 2026 MD&A, sensitivity of NPV and IRR to the uranium price (ITU, Q4-2023 dollars).
2.6 Peer positioning
The peer set for every star in Section 9 is three uranium companies, none in a pending deal: Cameco (TSX: CCO; NYSE: CCJ), Denison Mines (TSX: DML; NYSE American: DNN) and Paladin Energy (ASX: PDN; TSX: PDN). Each is compared on quality metrics from its own filings.
Table 3. Peer quality metrics
| Company | Listing | Stage | Reserves (mlb U₃O₈) | Output (mlb/yr) | Unit cost (US$/lb unless stated) | Funding |
|---|---|---|---|---|---|---|
| NexGen Energy | TSX: NXE / NYSE: NXE | Developer, under construction | 239.6 Probable at 2.37% (100%) | 30 design | 9.98 cash operating (study) | C$1.17 bn build gap |
| Cameco | TSX: CCO / NYSE: CCJ | Producer | 433.0 proven + probable (company share) | 21.0 (FY2025) | C$63.00–67.50 unit cost of sales incl. D&A (2026 outlook) | Net cash C$116.0 m |
| Denison Mines | TSX: DML / NYSE American: DNN | Developer, under construction | 103.0 Probable (100%) | 8.4 planned, first five years | 6.28 cash · 18.41 all-in (study) | C$559.2 m remaining, within cash and uranium held |
| Paladin Energy | ASX: PDN / TSX: PDN | Producer | 171.2 (LHM 77.5 JORC ore reserve + PLS 93.7 probable NI 43-101, 100%; 30 Jun 2025) | 4.82 (FY2026) | 43.3 cost of production (FY2026) | n/d (no net-cash line in the quarterly) |
Source: Cameco FY2025 and Q2 2026 MD&A; Denison Q2 2026 MD&A and Wheeler River study; Paladin FY2025 Annual Report (ore reserves at 30 June 2025) and quarterly report to 30 June 2026 (FY2026 output and cost); NexGen per Tables 1 and 2. Study costs are estimates, not realised costs.
Arrow is the largest planned operation in the set, larger than Cameco’s whole 2025 output, with the second-largest reserve. Only Denison’s study cost is lower, and against the producers the comparison is a study against a record: Cameco and Paladin report realised costs, NexGen and Denison study estimates. On funding NexGen is the weakest: it is the one peer with an unfunded build.
3. Financials & balance sheet
NexGen has no revenue, so its record is spend, cash and dilution. The net loss runs well above cash burn because the convertibles are carried at fair value through earnings.
Table 4. Five-year financial summary, FY2021–FY2025 (C$ m unless stated)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | nil | nil | nil | nil | nil |
| YoY % | n/m | n/m | n/m | n/m | n/m |
| Cash margin | n/m | n/m | n/m | n/m | n/m |
| Net income (loss) | (126.9) | (60.3) | 70.2 | (77.6) | (309.7) |
| EPS, basic and diluted (C$) | (0.26) | (0.12) | 0.16 | (0.14) | (0.53) |
| Operating cash flow | (16.8) | (20.2) | (52.6) | (24.1) | (47.5) |
| Capex (sustaining / growth) | nil / 45.7 | nil / 67.7 | nil / 109.7 | nil / 128.3 | nil / 185.1 |
| FCF | (62.5) | (87.9) | (162.4) | (152.4) | (232.6) |
| Net debt (net cash) | (129.8) | (54.4) | (132.3) | (20.8) | (537.5) |
| ND/EBITDA | n/m | n/m | n/m | n/m | n/m |
| Diluted shares (m) | 459.3 | 479.7 | 529.2 | 554.8 | 588.4 |
| DPS | nil | nil | nil | nil | nil |
Source: NexGen FY2025, FY2023 and FY2022 audited financial statements (statements of loss, cash flows and financial position; each carries the prior year — FY2021 from the FY2022 statements in the 40-F of 24 February 2023). Growth capex = expenditures on exploration and evaluation assets (no sustaining capex before production); FCF = operating cash flow − that capex. Net cash = cash + short-term investments − convertibles at fair value (FY2025: C$802.6 m + C$321.1 m − C$586.2 m). Diluted shares are the weighted averages behind diluted EPS. n/m: no revenue or EBITDA.
Cash burn is small against the balance sheet: operating outflow was C$20.5 m in H1 2026, while spending on the mine and on exploration was C$54.5 m and C$88.6 m.
Cost deck. The guided unit cost is the ITU’s C$13.86/lb cash operating cost. Price-linked lines are the 2% NSR and Saskatchewan’s royalties — in the FS, revenue royalties are 7.3% of gross revenue (C$1,129.1 m of C$15,573.2 m) plus C$1,683.5 m of profit royalties. Tax pools are not disclosed; non-capital losses of C$301.7 m expire 2030–2045.
Net cash and liquidity. At 30 June 2026 cash of C$756.2 m and short-term investments of C$214.1 m less C$0.7 m of leases give net cash of C$969.6 m. Against it sit US$360 m of 9% convertibles at face (fair value C$612.4 m): US$110 m converting at US$6.76 and maturing 22 September 2028, and US$250 m at US$10.73 maturing in 2029. No project debt is signed; lenders’ non-binding interest exceeds US$1 billion. ND/EBITDA cannot be stress-tested without EBITDA. The closure provision amount is not disclosed; C$15.5 m of assurances are posted.
Hedges. No uranium is hedged; USD/CAD forwards cover debenture-related US dollar flows. A 10% currency move changes the US$430.0 m of net financial liabilities by C$61.0 m.
Capital returns and shares. No dividend or buyback. The A$1 billion Global Offering (October 2025) issued 33.1 m shares at C$12.08 and 45.8 m CDIs at A$13.10; basic shares were 670,506,101 on 4 August 2026, plus 47,428,163 options. For reading these statements, see Financial Metrics for Commodity Investing.
4. Management, strategy & structure
4.1 Management & governance
Leigh Curyer founded NexGen and has been President, CEO and a director since 19 April 2013, after leading its predecessor from 2011. Christopher McFadden has chaired the board since 22 May 2014. Ryan Podrasky became CFO on 25 May 2026, succeeding Benjamin Salter, who stays on as an adviser; Podrasky was previously CFO of Elk Valley Resources, the former Teck coal business. Directors include Richard Patricio (President and CEO of Mega Uranium) and Sharon Birkett (appointed 17 June 2025; CFO of Multi-Color Corporation 2010–2022). Board size, independence and committees other than the Audit Committee are in the management information circular, which is not on hand. Directors and officers own 32,076,664 shares (~4.9%). Related parties: payables to Flying W Consulting (C$76k at 31 March 2026) and the shared IsoEnergy directorships.
4.2 Strategy
The strategy is to build Rook I and sell into utility term contracts. The 2026 Operations Outlook covers engineering, construction to schedule and offtake negotiation, with no dated production target. Contracting began with US utilities in December 2024; a 5 mlb agreement in August 2025 doubled contracted volume, and a 1 mlb-a-year contract followed in Q3 2025. Financing is sequenced as project debt, offtake and the equity already raised.
4.3 Ownership & structure
The most material transaction is the July 2025 purchase of Rio Tinto’s 10% carried interest, which made Rook I wholly owned (the price is not in the filings on hand). The 2023 Debentures (US$110 m) went to Queen’s Road Capital and Washington H. Soul Pattinson; the 2024 Debentures (US$250 m) went to MMCap for about 2.7 mlb of uranium, with an investor-rights agreement covering voting alignment and a standstill. NexGen holds Rook I directly, plus the IsoEnergy stake. The diluted count used in Section 7 is 706,694,859 (options by the treasury method).
5. ESG & sustainability
The licence to operate rests on four signed Benefit Agreements — with Clearwater River Dene Nation, Métis Nation–Saskatchewan (Northern Region 2), Birch Narrows Dene Nation and Buffalo River Dene Nation — covering every project phase, and on an underground tailings facility that returns tailings as paste backfill rather than to a surface dam. The 2024 Sustainability Report (June 2025) is GRI-referenced. Safety rates and emissions are not in the filings on hand, so this dimension is scored on programs, not outcomes.
6. Risks
Table 5. Risk register
| Risk | Type | Likelihood / impact | Exposure | Mitigant |
|---|---|---|---|---|
| Funding gap and dilution | Balance sheet | High / High | C$1,173.6 m unfunded; NAV per share | Lender interest over US$1 bn; offtake contracts |
| Schedule slip | Operational | Medium / High | One year later: NAV/share C$6.64 → C$6.04 | Licensed, construction under way |
| Capital overrun | Operational | Medium / High | C$2,133.5 m still to spend | ITU re-estimate; engineering continues |
| Uranium price | Commodity | Medium / High | NAV/share C$5.21 at US$75 vs C$6.64 at US$90 | Term contracts; cash cost US$9.98/lb |
| Single asset | Operational | High / High | 97.7% of enterprise NAV | Grade and jurisdiction |
| USD/CAD | Financial | Medium / Low | ±10%: NAV/share C$5.82 / C$7.46 | US$ debt offsets part |
Source: NexGen Q2 2026 MD&A and 2025 Annual Information Form; exposures per Section 7. Likelihood and impact are this analysis’s assessment.
Figure 5. Risk matrix — likelihood against impact
Source: Table 5. The shaded corner is high likelihood and high impact.
The funding gap and the single asset are one risk seen twice: every overrun or delay lands on one balance sheet with no operating cash flow, and new shares are the release valve. Section 7 prices three of these directly: the 0.75× stage weight carries the open financing, the one-year slip case carries the schedule, and the grid carries the uranium price. A capital overrun beyond the ITU estimate is not modelled; each extra C$100 million is at most about C$0.14 a share.
7. Valuation
Valuation as of 20 August 2026, in Canadian dollars. Horizon: spot fair value. Price deck: base uranium US$90/lb U₃O₈, the representative of the trailing averages of the month-end spot indicator — US$85.19 (3-month), US$85.52 (6-month) and US$83.54 (12-month) to 31 July 2026 — snapped to the fixed US$60–120/lb grid, with every grid price run as a scenario (deep bear US$60 / bear US$75 / base US$90 / bull US$105 / deep bull US$120). Discount rate 10% real, after-tax — the uranium single-asset rate, because Rook I is the only asset with a study — sensitised 8–12%. Share price C$14.55 (TSX close, 19 August 2026); 706.7 m shares diluted (670.5 m outstanding, 19.9 m from the 47.4 m options by the treasury method at their C$8.44 weighted average exercise price, and 16.3 m on the 2023 Debentures, whose US$6.76 conversion price sits below the US$10.49 share price); balance sheet at 30 June 2026; the US$ deck converts at US$1 = C$1.387 (19 August 2026).
NexGen is valued as a developer: Rook I, the Arrow deposit, holds a feasibility study and its 2024 Interim Trend Update, both federal and provincial approvals, and has been under licensed construction since 8 June 2026, with the project financing still open. The method follows the How to Value Commodity Stocks guide. Rook I is valued from the study’s own after-tax NPV at each uranium price, moved from the study’s 8% to 10% on a printed cash-flow profile, and carries its stage risk in a row weight of 0.75× — licensed and building, but not yet funded to completion — so the discount rate stays at the convention. The cash, the 2.7 Mlb uranium inventory and the debentures sit in the bridge. The developer’s transaction-comparison and EV-per-reserve methods have no filed deal and no uranium anchor to stand on, so the second weighted method is a free-cash-flow yield on Rook I’s first full production year, discounted back to today. The scorecard’s driver line (Table 11) sums to +0.12, so the P/NAV target moves from its 1.00× anchor to 1.12× and the FCF-yield target from 7% to 6.3%.
Table 6. Load-bearing inputs — the figures the valuation turns on (full source register: Table 19)
| Input | Value | Where §7 uses it | Source |
|---|---|---|---|
| Rook I Project — NexGen interest | 100% | Table 9, blocks 1–2 | Filed | Q2 2026 MD&A | Rook I Project overview | “developing into production the 100% owned Rook I Project” | p.6 |
| Arrow Probable reserve (100%) | 239.6 Mlb U₃O₈ at 2.37% | Table 9, block 2 — resource conversion | Filed | AIF 2024 | Mineral Reserve table | “Probable” | p.20 |
| Arrow Measured + Indicated, inclusive of reserves | 256,700,000 lb | Table 9, block 2 | Filed | AIF 2025 | Mineral Resource table | “Indicated Total” | p.17 |
| Pre-production capital, FS → Interim Trend Update | C$1.3bn → C$2.2bn | Table 9, block 1 — capital | Filed | AIF 2025 | Interim Trend Update | “C$1.3 billion in the Rook I FS Technical Report to approximately C$2.2 billion” | p.7 |
| ITU after-tax NPV 8% and FCF years 1–5 at US$90/lb (100%) | C$5.84bn · C$1.82bn a year | Table 9, block 1; Tables 12, 14 | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$90" | p.9 |
| ITU after-tax NPV 8% and FCF years 1–5 at US$100/lb (100%) | C$6.79bn · C$2.04bn a year | Table 9, block 1 — NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$100" | p.9 |
| Study FX basis (C$/US$) | 1.00:0.75 | Table 9 — deck to study terms | Filed | Q2 2026 MD&A | Sensitivity table note 1 | “at an exchange rate of C$/US$ of 1.00:0.75” | p.9 |
| Royalty on the Rook I claims (Advance Royalty) | 2% NSR | Table 9, block 1 — deck × (1 − 2%) | Filed | AIF 2025 | Property note | “subject to a 2% NSR royalty in favour of” | p.8 |
| Cash / short-term investments | C$756,173k / C$214,080k | Table 10 — net cash | Filed | Q2 2026 interim FS | Statement of financial position | “Cash” | p.2 |
| Strategic uranium inventory | 2.7 Mlb (cost C$341,150k) | Table 10 — investments at the deck | Filed | Q2 2026 MD&A | Liquidity | “including the strategic inventory of 2.7 M lbs of U” | p.15 |
| 2024 Debentures — conversion price (out of the money) | US$10.73 | Table 10 — convertible at face | Filed | Q2 2026 interim FS | Note 9 | “at a conversion price of US$10.73 into a maximum of 23,299,161” | p.11 |
| Shares, diluted basis | 706,694,859 | Table 10 — per share | Derived | 670,506,101 basic + 19,916,569 option shares — 47,428,163 options (Q2 2026 MD&A, Outstanding Share Data) × (1 − C$8.44 ÷ C$14.55) (Q2 2026 FS p.13) + 16,272,189 2023 Debenture shares (Q2 2026 FS note 9) |
| U₃O₈ spot, 3-, 6-, 12-month averages | US$85.19 · US$85.52 · US$83.54/lb | Figure 7, Table 15 — deck | Derived | means of the Cameco month-end spot prices to 31 Jul 2026 (series in Table 19) |
Source: each row’s filing as cited — NexGen’s Q2 2026 and FY2025 filings and the 2025 Annual Information Form on SEDAR+; deck rows per Cameco’s uranium price series.
8. Near-term catalysts (1–3 years)
Table 17. Near-term catalysts
| Catalyst | Expected timing | Why it benefits NexGen |
|---|---|---|
| Project debt facility signed | Not dated; lender interest over US$1 bn (2025 AIF) | Closes most of the C$1,173.6 m gap without new shares |
| Further utility offtake contracts | 2026 (Operations Outlook) | Contracted pounds underpin project debt |
| Patterson Corridor East maiden resource | Not dated | Pounds beyond Arrow’s ~8-year design-rate life |
| First production | Not dated by the company | Study cash flow becomes reported cash flow; a build held to the ITU estimate removes the overrun risk the stage weight prices |
Source: NexGen Q2 2026 MD&A, 2026 Operations Outlook, and the 2025 Annual Information Form. Timing follows company disclosure and is not a guarantee.
The catalysts run in one order — finance, build, produce. The first carries the most value: a debt package that closes the gap without equity would move the stage weight from 0.75× toward the funded 0.80×, where NAV/share is C$7.00.
8.1 Takeover optionality
The target case. Arrow is a licensed, wholly owned 239.6 mlb reserve at 2.37% in Saskatchewan, designed for 30 mlb a year — more than Cameco’s whole 2025 output — and with Rio Tinto’s carried interest bought out, a buyer would face no project partner.
The disqualifiers. At C$9.76 billion before any premium, NexGen is a transformational purchase, not a bolt-on. The 2% NSR, US$360 m of convertibles and MMCap’s standstill and voting-alignment rights travel with it, and Arrow would dominate any buyer’s risk profile.
Acquirers. No filing on hand links a named company to a bid or a stake, so none is named. The plausible type is a large producer or a utility-backed group seeking supply; utilities are already present as offtake buyers.
Effect on the verdict. None. Section 7 values NexGen standalone, and the fair value carries no takeover premium.
9. Rating & verdict
Figure 9. Scorecard by dimension, 20 August 2026
Figure data: Table 18. Each spoke prints its stars and weight; the dashed ring is the weighted composite, 4.00/5.
Table 18. Scorecard rationale
| Dimension | Weight | Score | Rationale |
|---|---|---|---|
| 5. Balance sheet & funding gap | 15% | ★★★ | Net cash C$969.6 m, the uranium inventory and the debentures cover 45% of the C$2,133.5 m still to spend; the C$1,173.6 m gap is 12.0% of market capitalisation with no project debt signed — the only unfunded build in the peer set (Q2 2026 FS, 30 Jun 2026; Table 3). |
| 7. Management & governance | 15% | ★★★★ | The founder-CEO, in post since 2013, took Arrow from discovery to a construction licence (5 Mar 2026), as Denison Mines took Phoenix to construction; insiders own ~4.9%; independence is not on hand and three directors sit on IsoEnergy’s board (2025 AIF). |
| 1. Asset quality & scale | 15% | ★★★★★ | 239.6 mlb probable at 2.37% U₃O₈ for 30 mlb/yr design — the largest planned output in the peer set, above Cameco’s 21.0 mlb FY2025 share; one asset carries 97.7% of NAV (2024 and 2025 AIFs; Table 3). |
| 3. Reserves, life & replacement | 15% | ★★★★ | 239.6 mlb probable, second of four behind Cameco’s 433.0 and ahead of Paladin’s 171.2 and Denison’s 103.0; 80.7 mlb inferred behind it, but no filed mine life (about eight years at the design rate) (2024 AIF, eff. 21 Jan 2021; Table 3). |
| 2. Cost position & margins | 8% | ★★★★ | Study estimate: ITU cash operating cost US$9.98/lb, an 88.9% margin at US$90 — far below Paladin’s US$43.3/lb realised cost, above Denison’s US$6.28/lb study cash cost (Q2 2026 MD&A; Table 3). |
| 4. Growth & optionality | 8% | ★★★★ | From nil to 30 mlb/yr design under licensed construction since 8 Jun 2026, against Denison’s 8.4 mlb/yr plan; Patterson Corridor East unresourced; the growth is only partly funded (Q2 2026 MD&A; Table 3). |
| 6. Capital allocation & returns | 8% | ★★★ | No dividend or buyback; basic weighted shares rose 16% (569.6 m in H1 2025 to 663.2 m in H1 2026) on the A$1 bn offering, while the Rio Tinto carried interest was bought out — in line with Denison Mines, which also funds its build with notes and equity (Q2 2026 FS). |
| 8. Jurisdiction & geopolitics | 8% | ★★★★★ | Saskatchewan, with the provincial EA (Nov 2023) and federal licence (5 Mar 2026) in hand — the jurisdiction of Cameco’s and Denison’s mines, ahead of Paladin’s Namibia (Q2 2026 MD&A). |
| 9. ESG & licence to operate | 8% | ★★★★ | Four signed Benefit Agreements and underground paste-backfill tailings — named programs in place before construction, as at Denison Mines; safety and emissions data not in the filings on hand (Q2 2026 MD&A; 2025 AIF). |
| Composite | 100% | ★★★★ | Solid |
Source: as cited per row — NexGen’s Q2 2026 filings and Annual Information Forms on SEDAR+; peers per Table 3. Every score is relative to the peer set declared in Section 2.6.
The arithmetic: 0.15 × (3 + 4 + 5 + 4) + 0.08 × (4 + 4 + 3 + 5 + 4) = 2.40 + 1.60 = 4.00/5 → ★★★★ Solid. Developer weights put the balance sheet, management, the asset and the reserve at 15% each and the other five at 8%.
The two-axis verdict: Solid (★★★★) and Fairly valued (wide band), implied +3.9%, as of 20 August 2026 → priced about right — a first-rate asset with its financing still open, at a price close to the blend.
The two axes answer different questions. The quality score rests on geology and jurisdiction that no financing changes; the value read rests on the stage weight and the deck, which the next year of financing news will move. A signed debt package at the adjacent funded weight lifts NAV/share to C$7.00 without changing a star.
The shares price in a market-implied uranium deck of ~US$87/lb, against a 12-month average of US$83.54; the target multiples carry Dimensions 1, 2, 3 and 8 (+0.12). Bull: project debt closes the gap without new equity and uranium holds above ~US$94/lb, where the read turns Modestly undervalued. Bear: a dilutive raise, an overrun or a slip, or uranium below ~US$80/lb turns it Modestly overvalued. To rank NexGen against every listed uranium name, screen the sector on Metal Pilot’s uranium mining stock screener.
10. Sources, methodology & disclaimer
10.1 Sources, methodology & data vintage
Company filings. NexGen’s Q2 2026 condensed interim financial statements and MD&A (balance sheet, debentures, approvals, the ITU sensitivity), FY2025, FY2023 and FY2022 audited financial statements, and the 2025 and 2024 Annual Information Forms (reserves, resources, design, encumbrances, governance), on SEDAR+ and SEC EDGAR; releases of 4 December 2024, 24 July 2025 and 6 August 2025.
Technical basis. The Rook I feasibility study (reserves effective 21 January 2021) as summarised in the Annual Information Form, and the Interim Trend Update (costs as of 1 August 2024) as reported in the Q2 2026 MD&A.
Market and peer data. Share price C$14.55 and USD/CAD 1.387 at the 19 August 2026 close per stockanalysis.com; uranium month-end prices from Cameco’s UxC/TradeTech series to 31 July 2026; peers from their filings (Table 3).
Methodology. Archetype: developer. The scorecard uses the developer weights against three peers. The valuation blends risked P/NAV (55%) and FCF-yield support (45%) on a base uranium deck of US$90/lb — the representative trailing average on the US$60–120/lb grid, with every grid price run as a scenario — at 10% real; the consensus target is a 0% cross-check. Data as of 20 August 2026; refreshed on each permitting, financing or construction milestone.
Re-run log. 11 October 2026: rework on the current template — model rebuilt on the 30 June 2026 balance sheet and the US$90/lb base, and the scorecard’s stars handed to the driver line; at C$14.55 the fair value is C$14.18, implied −2.5%, Fairly valued (wide band), from Modestly overvalued; quality 4.0/5 Solid, from 4.2/5. 11 October 2026 (gate fixes): the IsoEnergy stake carried at its filed C$256.6 million fair value and the options by the treasury method (706.7 m diluted) — NAV/share C$6.04 → C$6.64, blend C$14.18 → C$15.12, implied −2.5% → +3.9%; read unchanged, Fairly valued (wide band).
Omitted figures and data gaps. The asset map (one deposit reads clearly as Table 2) and a Section 3 cash chart (cash is in Table 4) are not built. Not in the source set: the Rook I feasibility study technical report (mine life, ramp, recovery), the 2026 management information circular (board) and the sustainability report (safety, emissions). The model’s full printout — P/NAV map, deck sensitivity and cross-checks — is claude/valuation-models/nexgen-energy-nxe.out.md.
Table 19. Full source register for the valuation (load-bearing subset: Table 6)
| Input | Value | As of | Where §7 uses it | Source |
|---|---|---|---|---|
| MD&A, six months ended 30 June 2026 | ||||
| Rook I Project (Arrow deposit) — NexGen interest; operator NexGen | 100% owned, operated | 30 Jun 2026 | NAV — attributable share | Filed | Q2 2026 MD&A | Rook I Project overview | "developing into production the 100% owned Rook I Project" | p.6 |
| CNSC federal EA approval and Licence to Prepare Site and Construct; Licence conditions resolved 22 May 2026 | 5 March 2026 | 22 May 2026 | Approvals in hand | Filed | Q2 2026 MD&A | Q2 2026 highlights | "issued a Licence to Prepare Site and Construct" | p.6 |
| Stage — licenced construction commenced (Rook I is a construction-stage developer) | commenced 8 June 2026 | 8 Jun 2026 | Stage — construction | Filed | Q2 2026 MD&A | Regulatory | "licenced construction activities commenced on June 8, 2026" | p.7 |
| Average cash operating cost — FS C$7.58/lb → ITU (US$ on the FS FX) | US$5.69/lb → C$13.86/lb (US$9.98/lb) | 1 Aug 2024 | Unit cost | Filed | Q2 2026 MD&A | Interim Trend Update | "to approximately C$13.86/lb (US$9.98/lb)" | p.9 |
| LOM sustaining capital incl. closure — FS → ITU | C$362.4m (closure C$69.5m) → ~C$785m (closure ~C$70m) | 1 Aug 2024 | Sustaining / closure | Filed | Q2 2026 MD&A | Interim Trend Update | "Sustaining capital costs are expected to increase from C$362.4 million" | p.9 |
| Rook I NPV8 sensitivity at US$100/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$2.11bn · payback 0.6 yr · IRR 81.6% · NPV C$8.13bn | ITU: FCF C$2.04bn · payback 1 yr · IRR 46.9% · NPV C$6.79bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$100" | p.9 |
| Rook I NPV8 sensitivity at US$90/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$1.90bn · payback 0.6 yr · IRR 76.8% · NPV C$7.20bn | ITU: FCF C$1.82bn · payback 1.1 yr · IRR 43.4% · NPV C$5.84bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$90" | p.9 |
| Rook I NPV8 sensitivity at US$80/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$1.68bn · payback 0.7 yr · IRR 71.5% · NPV C$6.27bn | ITU: FCF C$1.61bn · payback 1.2 yr · IRR 39.6% · NPV C$4.89bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$80" | p.9 |
| Rook I NPV8 sensitivity at US$70/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$1.47bn · payback 0.7 yr · IRR 65.8% · NPV C$5.33bn | ITU: FCF C$1.39bn · payback 1.3 yr · IRR 35.4% · NPV C$3.96bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$70" | p.9 |
| Rook I NPV8 sensitivity at US$60/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$1.25bn · payback 0.8 yr · IRR 59.5% · NPV C$4.40bn | ITU: FCF C$1.18bn · payback 1.6 yr · IRR 30.7% · NPV C$3.04bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$60" | p.9 |
| Rook I NPV8 sensitivity at US$40/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$0.82bn · payback 1.1 yr · IRR 44% · NPV C$2.53bn | ITU: FCF C$0.76bn · payback 2.6 yr · IRR 18.9% · NPV C$1.19bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$40" | p.9 |
| Rook I NPV8 sensitivity at US$30/lb (100%, after-tax; FS Q4-2020 $ vs ITU Q4-2023 $) | FS: FCF Y1-5 C$0.61bn · payback 1.3 yr · IRR 33.8% · NPV C$1.59bn | ITU: FCF C$0.55bn · payback 3.8 yr · IRR 10.5% · NPV C$0.23bn | 1 Aug 2024 | Study NPV by price | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$30" | p.9 |
| Rook I NPV8 at the FS base case US$50/lb (100%, after-tax) | FS: FCF Y1-5 C$1.04bn · payback 0.9 yr · IRR 52.4% · NPV C$3.47bn | ITU: FCF C$0.97bn · payback 2 yr · IRR 25.2% · NPV C$2.10bn | 1 Aug 2024 | Study NPV — base | Filed | Q2 2026 MD&A | Sensitivity of NPV and IRR to Uranium Price | "$50 (FS Base Case)" | p.9 |
| Study basis — FS FX (US$1.00 = C$1.33) and 100% of production sold at the deck | C$/US$ 1.00:0.75 | 30 Jun 2026 | Deck basis / FX | Filed | Q2 2026 MD&A | Sensitivity table note 1 | "at an exchange rate of C$/US$ of 1.00:0.75" | p.9 |
| Study discount rate (FS base case) | 8% | 30 Jun 2026 | Discount rate basis | Filed | Q2 2026 MD&A | Sensitivity table note 1 | "The Base Case from the Rook I FS Technical Report uses a discount rate of 8%" | p.9 |
| Strategic inventory volume | 2.7 Mlb U3O8 | 30 Jun 2026 | Bridge — physical uranium volume | Filed | Q2 2026 MD&A | Liquidity | "including the strategic inventory of 2.7 M lbs of U" | p.15 |
| Shares outstanding and options — 4 Aug 2026 (MD&A date) | 670,506,101 shares · 47,428,163 options | 4 Aug 2026 | Share count — basic | Filed | Q2 2026 MD&A | Outstanding Share Data | "there were 670,506,101 Shares" | p.18 |
| Investment in associate — IsoEnergy Ltd. ownership, 30 Jun 2026 | ~27.8% | 30 Jun 2026 | Bridge — investments (mark at market) | Filed | Q2 2026 MD&A | Rook I Project overview | "The Company holds an investment in IsoEnergy" | p.6 |
| Annual Information Form, year ended 31 December 2024 | ||||
| Arrow Probable Mineral Reserve (100%; no Proven; NI 43-101, Rook I FS, effective 21 Jan 2021 per the FS TR — date not printed on this line) | 4,575 kt at 2.37% U3O8 for 239.6 Mlb | 21 Jan 2021 | NAV — reserve | Filed | AIF 2024 | Mineral Reserve table | "Probable" | p.20 |
| Annual Information Form, year ended 31 December 2025 | ||||
| Arrow Measured + Indicated resource (100%, inclusive of reserves) | 3,754,000 t at 3.10% U3O8 for 256,700,000 lb | 21 Jan 2021 | Resource-conversion row | Filed | AIF 2025 | Mineral Resource table | "Indicated Total" | p.17 |
| Arrow Measured resource (209.6 Mlb U3O8 on the next line of the AIF) | 2.18 Mt at 4.35% U3O8 | 21 Jan 2021 | Resource split | Filed | AIF 2025 | Mineral Resources | "Measured Mineral Resources total 2.18 Mt at an average grade of 4.35%" | p.16 |
| Arrow Indicated resource | 1.57 Mt at 1.36% U3O8 | 21 Jan 2021 | Resource split | Filed | AIF 2025 | Mineral Resources | "Indicated Mineral Resources total 1.57 Mt at an average grade of 1.36%" | p.16 |
| Arrow Inferred resource (80.7 Mlb U3O8 on the next line of the AIF) | 4.40 Mt at 0.83% U3O8 | 21 Jan 2021 | Resource-conversion row — inferred | Filed | AIF 2025 | Mineral Resources | "Inferred Mineral Resources total 4.40 Mt at an average grade of 0.83%" | p.16 |
| Rook I design — plant throughput and design production (FS) | 1,300 t/d · 30 Mlb U3O8/yr | 21 Jan 2021 | Annuity — volume | Filed | AIF 2025 | Mineral processing | "Plant throughput will be 1,300 t/d and design production will be 30 M" | p.20 |
| Pre-production capital — FS → Interim Trend Update (ITU, costs as of 1 Aug 2024) | C$1.3bn → C$2.2bn (incl. C$310m inflation) | 1 Aug 2024 | Remaining capital | Filed | AIF 2025 | Interim Trend Update | "C$1.3 billion in the Rook I FS Technical Report to approximately C$2.2 billion" | p.7 |
| ITU capital increase — inflation since 2020 and incremental capital from advanced engineering | C$310m inflation · C$590m incremental | 1 Aug 2024 | Remaining capital — basis | Filed | AIF 2025 | Interim Trend Update | "C$310 million in inflationary adjustments since 2020 and approximately C$590 million in incremental capital costs" | p.11 |
| 2% NSR royalty on certain Rook I claims in favour of Advance Royalty Corporation (buy-down terms in the AIF note) | 2% NSR | 31 Dec 2025 | Encumbrance | Filed | AIF 2025 | Property note | "subject to a 2% NSR royalty in favour of" | p.8 |
| Project debt — non-binding expressions of interest (no facility signed; no undrawn facility) | over US$1bn | 31 Dec 2025 | Funding gap | Filed | AIF 2025 | Three-year history | "expressions of interest totaling over US$1 billion in available debt" | p.6 |
| Condensed interim FS, 30 June 2026 | ||||
| Expenditures on MPP&E — Q2 2026 and six months 2026 | Q2 C$30,660k · H1 C$54,548k | 30 Jun 2026 | Remaining capital — spent to date | Filed | Q2 2026 interim FS | Statement of cash flows | "Expenditures on mineral property, plant and equipment" | p.4 |
| Advances for MPP&E — Q2 2026 and six months 2026 | Q2 C$6,584k · H1 C$12,000k | 30 Jun 2026 | Remaining capital — spent to date | Filed | Q2 2026 interim FS | Statement of cash flows | "Advances for mineral property, plant and equipment" | p.4 |
| Decommissioning financial assurances posted (surety bonds) | C$15,472k | 30 Jun 2026 | Closure — security | Filed | Q2 2026 interim FS | Note — commitments | "has provided financial assurances of $15,472" | p.15 |
| Cash — 30 Jun 2026 (31 Dec 2025) | C$756,173k (C$802,578k) | 30 Jun 2026 | Net cash — bridge | Filed | Q2 2026 interim FS | Statement of financial position | "Cash" | p.2 |
| Short-term investments — 30 Jun 2026 (31 Dec 2025) | C$214,080k (C$321,084k) | 30 Jun 2026 | Net cash — bridge | Filed | Q2 2026 interim FS | Statement of financial position | "Short-term investments" | p.2 |
| Restricted cash — 30 Jun 2026 (31 Dec 2025) | C$5,250k (C$8,000k) | 30 Jun 2026 | Bridge — restricted | Filed | Q2 2026 interim FS | Note — financial instruments | "Restricted cash" | p.15 |
| Strategic inventory — ~2.7 Mlb U3O8 at cost (bought for the US$250m 2024 Debentures) | C$341,150k | 30 Jun 2026 | Bridge — physical uranium (mark at deck) | Filed | Q2 2026 interim FS | Statement of financial position | "Strategic inventory" | p.2 |
| Accounts receivable — 30 Jun 2026 (31 Dec 2025) | C$3,102k (C$2,232k) | 30 Jun 2026 | Working capital | Filed | Q2 2026 interim FS | Note — financial instruments | "Accounts receivable" | p.15 |
| Accounts payable and accrued liabilities — 30 Jun 2026 (31 Dec 2025) | C$59,699k (C$40,347k) | 30 Jun 2026 | Working capital | Filed | Q2 2026 interim FS | Statement of financial position | "Accounts payable and accrued liabilities" | p.2 |
| Interest payable — 30 Jun 2026 (31 Dec 2025) | C$2,682k (C$2,594k) | 30 Jun 2026 | Bridge — debt | Filed | Q2 2026 interim FS | Statement of financial position | "Interest payable" | p.2 |
| Lease liabilities — 30 Jun 2026 (31 Dec 2025) | C$697k (C$697k) | 30 Jun 2026 | Bridge — leases | Filed | Q2 2026 interim FS | Statement of financial position | "Lease liabilities" | p.2 |
| Convertible debentures — aggregate principal at face (2023 US$110m + 2024 US$250m) | US$360m | 30 Jun 2026 | Bridge — convertibles at face | Filed | Q2 2026 interim FS | Note — foreign exchange risk | "At maturity, the aggregate US$360 million principal amount" | p.16 |
| 2023 Debentures — 9% (6% cash / 3% shares), conversion price, maximum shares | US$6.76 · 16,272,189 shares | 30 Jun 2026 | Dilution — in the money | Filed | Q2 2026 interim FS | Note 9 | "at a conversion price of US$6.76 into a maximum of 16,272,189" | p.11 |
| 2024 Debentures — 9% (6% cash / 3% shares), conversion price, maximum shares | US$10.73 · 23,299,161 shares | 30 Jun 2026 | Dilution — convertible | Filed | Q2 2026 interim FS | Note 9 | "at a conversion price of US$10.73 into a maximum of 23,299,161" | p.11 |
| 2023 Debentures — US$110m private placement (QRC, WHSP), maturity 22 Sep 2028 | US$110m · 2028 | 30 Jun 2026 | Maturities | Filed | Q2 2026 interim FS | Note 9 | "US$110 million private placement of unsecured convertible debentures" | p.11 |
| 2024 Debentures — US$250m issued to MMCap for ~2.7 Mlb U3O8, five-year, maturity 2029 | US$250m · 2029 | 30 Jun 2026 | Maturities | Filed | Q2 2026 interim FS | Note 9 | "US$250 million of unsecured convertible" | p.11 |
| Total assets — 30 Jun 2026 (31 Dec 2025) | C$2,528,326k (C$2,472,933k) | 30 Jun 2026 | Balance sheet | Filed | Q2 2026 interim FS | Statement of financial position | "Total assets" | p.2 |
| Hedge book — USD/CAD forward contracts on debenture-related US$ cash flows (figures on the line: US$82.5m, US$60m, C$1.3851; terms to be read in the note by Phase B); no uranium price hedges disclosed | US$82.5m · US$60m · 1.3851 | 30 Jun 2026 | Hedge book | Filed | Q2 2026 interim FS | Note — foreign exchange risk | "At maturity, the aggregate US$360 million" | p.16 |
| Fair value of the IsoEnergy investment (Level 1, closing price) — 30 Jun 2026 | C$256,576k | 30 Jun 2026 | Bridge — investments (IsoEnergy at fair value) | Filed | Q2 2026 interim FS | Note 7 — investment in associate | "Fair value of investment in associate as at June 30, 2026" | p.9 |
| Options outstanding and weighted average exercise price — 30 Jun 2026 | 39,618,162 options · C$8.44 | 30 Jun 2026 | Dilution — options, treasury method | Filed | Q2 2026 interim FS | Stock options note | "At June 30, 2026 - Outstanding" | p.13 |
| Annual FS, year ended 31 December 2025 | ||||
| Cash used in operating activities — FY2025, FY2024 | C$(47,512)k · C$(24,087)k | 31 Dec 2025 | Five-year table — OCF | Filed | FY2025 FS | Statement of cash flows | "Cash used in operating activities" | p.7 |
| Non-capital losses available for future periods, expiry | C$301,724k, 2030–2045 | 31 Dec 2025 | Tax basis | Filed | FY2025 FS | Note — income taxes | "Non-capital losses available for future periods" | p.27 |
| Market data and the live post's recorded inputs, 19 Aug 2026 | ||||
| NXE close, TSX (US$10.49 NYSE equivalent) — the live post's as-of | C$14.55 (US$10.49) | 19 Aug 2026 | §1 statcard; per-share | Market | stockanalysis.com | "TSX:NXE daily close" | 19 Aug 2026 |
| FX USD/CAD on the as-of date | US$1.00 = C$1.387 | 19 Aug 2026 | FX | Market | the live post's assumptions box | "FX US$1.00 = C$1.387" | 19 Aug 2026 |
| Analyst consensus — average target and buy share (captured for the live post on or before the as-of) | US$15.81 · ~81% buy | 19 Aug 2026 | Cross-check only (0% weight) | Market | stockanalysis.com | "analyst price target" | 19 Aug 2026 |
| Uranium spot price, month-end, Aug 2025 – Jul 2026 (US$/lb) | 75.13 · 82.63 · 80.00 · 75.80 · 81.55 · 94.28 · 86.95 · 84.25 · 86.35 · 84.18 · 85.00 · 86.38 | 31 Jul 2026 | §7 deck base | Market | Cameco | "Uranium price — spot / long-term, month-end" | 31 Aug 2025 – 31 Jul 2026 |
| Uranium trailing averages to Jul 2026 (US$/lb): spot 3 / 6 / 12-month; long-term 3 / 6 / 12-month | spot 85.19 / 85.52 / 83.54; long-term 95.00 / 93.00 / 89.04 | 31 Jul 2026 | §7 deck — 3/6/12-month bases | Derived | means of the Cameco month-end spot row above and the long-term month-end row (Cameco uranium price page) |
| Uranium spot, 12-month high and low to Jul 2026 (month-end) | high US$94.28 (Jan 2026); low US$75.13 (Aug 2025) | 31 Jul 2026 | §7 cycle high/low | Market | Cameco | "Uranium price — spot / long-term, month-end" | 31 Aug 2025 – 31 Jul 2026 |
| Uranium five-year average, Aug 2021 – Jul 2026 (US$/lb): spot; long-term | 67.82; 67.96 | 31 Jul 2026 | §7 deck — five-year reference | Derived | mean of 60 month-end values, Cameco uranium price page (UxC/TradeTech), saved 10 Oct 2026 |
| Shares, diluted basis — basic + options by the treasury method (47,428,163 at the C$8.44 weighted average exercise price, 30 Jun 2026: 19,916,569 dilutive) + 2023 Debentures if-converted (US$6.76 below the US$10.49 price); 2024 Debentures out of the money (US$10.73) | 706,694,859 | 4 Aug 2026 | Per share | Derived | 670,506,101 basic + 19,916,569 option shares — 47,428,163 options (Q2 2026 MD&A, Outstanding Share Data) × (1 − C$8.44 ÷ C$14.55) (Q2 2026 FS p.13) + 16,272,189 2023 Debenture shares (Q2 2026 FS note 9) |
Source: each row’s filing as cited — NexGen’s Q2 2026 and FY2025 filings, the 2024 and 2025 Annual Information Forms and releases on SEDAR+; market rows as dated.
10.2 Disclaimer & disclosure
This analysis is for information only and is not investment advice. Do your own research or consult a licensed adviser. It is a point-in-time snapshot as of 20 August 2026: the price, the valuation and the verdict move with the market and the uranium price, and a pre-production developer’s value swings on financing and construction news. Reserves and study economics are estimates, not results. The quality rating and value read are analytical judgements, not a recommendation to buy or sell. This report was prepared with AI assistance from primary filings; verify anything material before acting. As of 18 November 2026, the author holds no position in the company this analysis covers.